ロード中...
Experience of Anti-Viral Therapy in Hepatitis B-Associated Membranous Nephropathy, Including Lamivudine-Resistant Strains
BACKGROUND/AIMS: Chronic hepatitis B infection is a common cause of secondary membranous nephropathy (MN) in endemic areas. Lamivudine treatment improves renal outcome in patients with hepatitis B virus-associated MN (HBV-MN), but prolonged use leads to the emergence of lamivudine-resistant variants...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Association of Internal Medicine
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3529240/ https://ncbi.nlm.nih.gov/pubmed/23269882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2012.27.4.411 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|